Claraphi Advisory Network, LLC Amgen Inc Transaction History

Claraphi Advisory Network, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	BUY	$230.71 - $256.74 $573,083 - $637,742	2,484 New	2,484 $604,000
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $110,773 - $135,934	-560 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $102,054 - $135,352	560 New	560 $114,000
Q3 2019 Nov 08, 2019	SELL	$174.11 - $208.62 $202,141 - $242,207	-1,161 Closed	0 $0
Q2 2019 Jul 29, 2019	BUY	$166.7 - $195.41 $193,538 - $226,871	1,161 New	1,161 $214,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Claraphi Advisory Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Claraphi Advisory Network, LLC with notifications on news.